Monoclonal Antibodies and Antivirals against SARS-CoV-2 Reduce the Risk of Long COVID: A Retrospective Propensity Score-Matched Case-Control Study von Cimellaro, Antonio, Addesi, Desirée, Cavallo, Michela, Spagnolo, Francesco, Suraci, Edoardo, Cordaro, Raffaella, Spinelli, Ines, Passafaro, Francesco, Colosimo, Manuela, Pintaudi, Medea, Pintaudi, Carmelo, On Behalf Of The CATAnzaro LOng Covid Cataloco Study Group

Volltext